C. Townsley

发表

G. Pond, A. Oza, J. Dancey, 2000, Women alive.

Antiangiogenic therapies in ovarian cancer

A. Oza, C. Townsley, 2010 .

Understanding the attitudes of the elderly towards enrolment into cancer clinical trials

Kelvin K. W. Chan, G. Pond, S. Straus, 2006, BMC Cancer.

Are O lder C ancer P atients B eing R eferred t o O ncologists? A M ail Q uestionnaire o f O ntario P rimary C are P ractitioners to E valuate T heir R eferral P atterns

G. Pond, S. Straus, L. Siu, 2003 .

Are older cancer patients being referred to oncologists? A mail questionnaire of Ontario primary care practitioners to evaluate their referral patterns.

G. Pond, S. Straus, L. Siu, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study

D. Cescon, P. Bedard, P. Goodwin, 2020, npj Breast Cancer.

Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer

G. Pond, A. Oza, J. Dancey, 2006, British Journal of Cancer.

Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer

G. Pond, R. Riechelmann, J. Knox, 2007, Cancer.

Characterisation of the lung toxicity of the cell cycle inhibitor temsirolimus.

G. Pond, A. Oza, L. Seymour, 2006, European journal of cancer.

A phase II study of aflibercept (VEGF trap) in recurrent or metastatic gynecologic soft-tissue sarcomas: A study of the Princess Margaret Hospital Phase II Consortium.

H. Mackay, A. Oza, R. Buckanovich, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The development and implementation of the After Cancer Treatment Transition (ACTT) Program for survivors of cancer.

Shari L Moura, C. Townsley, Patricia Nguyen, 2022, Canadian oncology nursing journal = Revue canadienne de nursing oncologique.

Phase II study of sorafenib (BAY 43-9006) in combination with gemcitabine in recurrent epithelial ovarian cancer: A PMH phase II consortium trial.

G. Pond, A. Oza, H. Hirte, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expanded phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors

G. Pond, A. Oza, L. Siu, 2007 .

Concurrent gemcitabine and radiotherapy with and without neoadjuvant gemcitabine for locally advanced unresectable or resected pancreatic cancer: a phase I-II study.

G. Pond, A. Oza, D. Hedley, 2007, International journal of radiation oncology, biology, physics.

Examining Predictors of Fear of Cancer Recurrence Using Leventhal's Commonsense Model: Distinct Implications for Oncology Nurses.

K. Metcalfe, C. Maheu, J. Galica, 2019, Cancer nursing.

A Phase II Trial with Pharmacodynamic Endpoints of the Proteasome Inhibitor Bortezomib in Patients with Metastatic Colorectal Cancer

H. Mackay, A. Oza, D. Birle, 2005, Clinical Cancer Research.

The Influence of Mentorship on Research Productivity in Oncology

G. Pond, R. Riechelmann, L. Siu, 2007, American journal of clinical oncology.

A phase I and pharmacokinetic (PK) study of continuous daily administration of P1446A-05, a potent and specific oral Cdk4 inhibitor.

A. Oza, S. Welch, Q. Chu, 2012 .

Phase II study of troxacitabine (BCH-4556) in patients with advanced and/or metastatic renal cell carcinoma: a trial of the National Cancer Institute of Canada-Clinical Trials Group.

I. Tannock, K. Bélanger, L. Seymour, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials.

L. Siu, Lillian L Siu, Rita Selby, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association between BMI, vitamin D, and estrogen levels in postmenopausal women using adjuvant letrozole: a prospective study

D. Cescon, Philippe Bédard, P. Goodwin, 2020, npj Breast Cancer.

Analysis of treatment practices for elderly cancer patients in Ontario, Canada.

G. Pond, S. Straus, L. Siu, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparing attitudes of younger and older patients towards cancer clinical trials.

M. Akhtar, A. Horgan, P. Calvert, 2016, Journal of geriatric oncology.

Examining the dimensionality of the Fear of Cancer Recurrence Inventory

K. Metcalfe, C. Maheu, J. Galica, 2018, Psycho-oncology.

Sorafenib Increases Tumor Hypoxia in Cervical Cancer Patients Treated With Radiation Therapy: Results of a Phase 1 Clinical Study.

M. Haider, H. Mackay, A. Oza, 2016, International journal of radiation oncology, biology, physics.

Evaluation of Adverse Events Experienced by Older Patients Participating in Studies of Molecularly Targeted Agents Alone or in Combination

G. Pond, A. Oza, H. Hirte, 2006, Clinical Cancer Research.

Outcomes of Early Transition of Low-Risk Thyroid Cancer Patients from Specialist to Primary Care

C. Townsley, A. Zahedi, Patricia Nguyen, 2022, Current oncology.

A phase I/II study of cisplatin and radiation in combination with sorafenib in cervical cancer: Evaluation of biomarkers.

M. Haider, H. Mackay, A. Oza, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.